Spain to introduce a fee per visit system?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.606, 2010-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Australia introduce lamivudine for chronic hep B?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Amoxicillin: prescribe at first visit for AOM?

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Infliximab, etanercept worthwhile for RA in Spain?

Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Farmaindustria, Spain's drug industry federation, has asked the Ministry of Health to introduce its new reference pricing system gradually

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 468, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Legitimate patent extension or patent system abuse?

By Atkinson Jonathan DM Moodie Rachel S

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 317-324

Future Science

Access to resources Recommend Favorite